Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Value of real-time elastography targeted biopsy for prostate cancer detection in men with prostate specific antigen 1.25 ng/ml or greater and 4.00 ng/ml or less.

Aigner F, Pallwein L, Junker D, Schäfer G, Mikuz G, Pedross F, Mitterberger MJ, Jaschke W, Halpern EJ, Frauscher F.

J Urol. 2010 Sep;184(3):913-7. doi: 10.1016/j.juro.2010.05.026.

PMID:
20643432
2.

Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy.

Pelzer A, Bektic J, Berger AP, Pallwein L, Halpern EJ, Horninger W, Bartsch G, Frauscher F.

J Urol. 2005 Jun;173(6):1926-9.

PMID:
15879783
3.

[Value of real-time elastography to guide the systematic prostate biopsy in men with normal digital rectal exam].

Brock M, Eggert T, Löppenberg B, Braun K, Roghmann F, Palisaar RJ, Noldus J, von Bodman C.

Aktuelle Urol. 2013 Jan;44(1):40-4. doi: 10.1055/s-0032-1333257. Epub 2013 Jan 16. German.

PMID:
23325671
4.

Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.

Tan N, Lane BR, Li J, Moussa AS, Soriano M, Jones JS.

J Urol. 2008 Oct;180(4):1325-9; discussion 1329. doi: 10.1016/j.juro.2008.06.022. Epub 2008 Aug 15.

PMID:
18707706
5.

Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter.

Horninger W, Cheli CD, Babaian RJ, Fritsche HA, Lepor H, Taneja SS, Childs S, Stamey TA, Sokoll LJ, Chan DW, Brawer MK, Partin AW, Bartsch G.

Urology. 2002 Oct;60(4 Suppl 1):31-5.

PMID:
12384160
6.

Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening.

Moul JW, Sun L, Hotaling JM, Fitzsimons NJ, Polascik TJ, Robertson CN, Dahm P, Anscher MS, Mouraviev V, Pappas PA, Albala DM.

J Urol. 2007 Feb;177(2):499-503; discussion 503-4.

PMID:
17222618
7.

Risk of prostate cancer for young men with a prostate specific antigen less than their age specific median.

Loeb S, Nadler RB, Roehl KA, Antenor JA, Catalona WJ.

J Urol. 2007 May;177(5):1745-8.

PMID:
17437803
8.
9.

Population-based screening for prostate cancer by measuring total serum prostate-specific antigen in Iran.

Hosseini SY, Moharramzadeh M, Ghadian AR, Hooshyar H, Lashay AR, Safarinejad MR.

Int J Urol. 2007 May;14(5):406-11.

11.
13.

Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL.

Törnblom M, Norming U, Adolfsson J, Becker C, Abrahamsson PA, Lilja H, Gustafsson O.

Urology. 1999 May;53(5):945-50.

PMID:
10223488
14.

The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.

Schoenfield L, Jones JS, Zippe CD, Reuther AM, Klein E, Zhou M, Magi-Galluzzi C.

BJU Int. 2007 Apr;99(4):770-4. Epub 2007 Jan 16.

15.

Predictors of cancer in repeat extended multisite prostate biopsy in men with previous negative extended multisite biopsy.

Mian BM, Naya Y, Okihara K, Vakar-Lopez F, Troncoso P, Babaian RJ.

Urology. 2002 Nov;60(5):836-40.

PMID:
12429311
16.

Prostate specific antigen velocity in men with total prostate specific antigen less than 4 ng/ml.

Loeb S, Roehl KA, Nadler RB, Yu X, Catalona WJ.

J Urol. 2007 Dec;178(6):2348-52; discussion 2352-3. Epub 2007 Oct 22.

PMID:
17936844
17.

Real-time elastography for the diagnosis of prostate cancer: evaluation of elastographic moving images.

Miyagawa T, Tsutsumi M, Matsumura T, Kawazoe N, Ishikawa S, Shimokama T, Miyanaga N, Akaza H.

Jpn J Clin Oncol. 2009 Jun;39(6):394-8. doi: 10.1093/jjco/hyp026. Epub 2009 Apr 9.

PMID:
19359330
18.

Prostate cancer detection among men with prostate specific antigen levels of 2.5 to 4.0 ng/ml in a Japanese urological referral population.

Kobayashi T, Mitsumori K, Kawahara T, Nishizawa K, Ogura K, Ide Y.

J Urol. 2006 Apr;175(4):1281-5.

PMID:
16515980
19.

Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection.

Eskicorapci SY, Guliyev F, Akdogan B, Dogan HS, Ergen A, Ozen H.

J Urol. 2005 May;173(5):1536-40.

PMID:
15821481
20.

Saturation technique does not decrease cancer detection during followup after initial prostate biopsy.

Lane BR, Zippe CD, Abouassaly R, Schoenfield L, Magi-Galluzzi C, Jones JS.

J Urol. 2008 May;179(5):1746-50; discussion 1750. doi: 10.1016/j.juro.2008.01.049. Epub 2008 Mar 17.

PMID:
18343412

Supplemental Content

Support Center